Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.



ROUNDTABLE FORUM: MEDICAL TECHNOLOGY: SMALL CAP STOCKS


Full article published: 09/20/1999


For Subscribers

Get this article online now!

Order just this article
TWST: Let's start by establishing the parameters of what constitutes small capitalization or, small to medium capitalization, medical technology stocks. Michael?
Mr. Mullen: I have generally thought of small cap as stocks with market caps of roughly $1 billion or less. We could stretch the definition to include the few medical device stocks with market caps up to $3 billion. Stocks at the other end of the spectrum, say under $400 million in market cap, are sometimes referred to as emerging growth. But for this discussion, let's just say $1 billion or less.

TWST: Rick, are we talking about companies under $1 billion, under $500 million? What are the smallest companies that you include in your universe?
Mr. Wise: The definition of less than $1 billion market cap for the small cap universe is a very good one. One challenge in this environment, in regard to the current stock market environment, is that many people are expanding that definition, and as I go around and talk to institutions, to my surprise, they sometimes consider smaller cap names or medium cap names in the $1-5 billion market cap range. This could just reflect the appreciation in the market. But certainly, in my mind, less than $1 billion for small caps is an accurate statement. We then have the emerging technology companies that are less than $100 million these days. So in conclusion, I believe that the small cap universe can be summed up as, beauty or size , is in the eye of the beholder'.

 

Tickers included in this excerpt: ACN, BDX, BEAM, CBMI, DGX, DSCP, GDT, IDXX, KERA, MDT, MNMD, NOVT, OCLR, PERC, SMPX, STJ, SYK, VISX, VMSI, WJCO, XOMD

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.